Clinical Trials Logo

Clinical Trial Summary

An indirect comparison to compare the efficacy of eltrombopag versus romiplostim


Clinical Trial Description

An indirect analysis was conducted to evaluate the relative efficacy of eltrombopag and romiplostim using placebo as a common comparator ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01236014
Study type Observational
Source GlaxoSmithKline
Contact
Status Completed
Phase N/A
Start date August 2009
Completion date October 2009

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01440374 - A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia Phase 2
Completed NCT01957176 - A Rollover Study to Provide Continued Treatment With Eltrombopag Phase 4
Withdrawn NCT01055600 - Milk-only Lactation Study for Patients on Eltrombopag Phase 4
Completed NCT01147809 - Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag Phase 2
Terminated NCT02158936 - A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) Phase 3
Completed NCT00358540 - Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide Phase 1
Completed NCT00102726 - SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy Phase 2
Completed NCT01235988 - Meta-analysis - Eltrombopag N/A
Completed NCT01657552 - Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects Phase 1